Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic review
Felice Iasevoli, Annarita Barone, Elisabetta Filomena Buonaguro, et al.
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 11, pp. 1419-1444
Closed Access | Times Cited: 21

Showing 21 citing articles:

Mental health problems in children with intellectual disability
Vasiliki Totsika, Ashley Liew, Michael Absoud, et al.
The Lancet Child & Adolescent Health (2022) Vol. 6, Iss. 6, pp. 432-444
Open Access | Times Cited: 66
Clozapine’s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia
Andrea de Bartolomeis, Licia Vellucci, Annarita Barone, et al.
Pharmacology & Therapeutics (2022) Vol. 236, pp. 108236-108236
Open Access | Times Cited: 49
Clozapine for persons with neurodevelopmental disorders: a systematic review and expert recommendations for clinical practice
Hélène Verdoux, Clélia Quilès, José de León
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 10, pp. 923-933
Closed Access | Times Cited: 5
Autism Spectrum Disorder and Epilepsy: Pathogenetic Mechanisms and Therapeutic Implications
Alessandra Giliberti, Adele Maria Frisina, Stefania Giustiniano, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2431-2431
Open Access
Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines
Anwesha Gangopadhyay, Radwa Ibrahim, Karli Theberge, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 20
Personal Quality of Life as an Outcome Measure of Antipsychotic Drug Management of Problem Behaviours in Adults with Intellectual Developmental Disorders with or Without Autism Spectrum Disorder
Marco O. Bertelli, Annamaria Bianco, Micaela Piva Merli, et al.
Brain Sciences (2025) Vol. 15, Iss. 3, pp. 316-316
Open Access
Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder
Viktor Román, Nika Adham, Andrew Foley, et al.
Psychopharmacology (2021) Vol. 238, Iss. 9, pp. 2381-2392
Open Access | Times Cited: 20
An expert opinion on the pharmacological interventions for Disruptive Mood Dysregulation Disorder (DMDD)
Laura Orsolini, Giulio Longo, Angelica Cicolini, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 1, pp. 67-78
Closed Access | Times Cited: 2
Can bumetanide be a miraculous medicine for autism spectrum disorder: Meta-analysis evidence from randomized controlled trials
Hongli Xiao, Han Zhu, Jia-Qi Jing, et al.
Research in autism spectrum disorders (2024) Vol. 114, pp. 102363-102363
Closed Access | Times Cited: 2
The metabolic adverse effects of antipsychotic use in individuals with intellectual and/or developmental disability: A systematic review and meta‐analysis
Emily R. Smith, Nicolette Stogios, Emily Au, et al.
Acta Psychiatrica Scandinavica (2022) Vol. 146, Iss. 3, pp. 201-214
Closed Access | Times Cited: 10
Intellectual Disability
Renée M. Green, Ainsley Losh
(2024), pp. 27-40
Closed Access | Times Cited: 1
Aripiprazole for the treatment of Tourette syndrome
Joanna H. Cox, Andrea E. Cavanna
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 4, pp. 381-391
Closed Access | Times Cited: 10
Current and emerging pharmacotherapeutic strategies for Tourette syndrome
Andrea E. Cavanna
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 13, pp. 1523-1533
Open Access | Times Cited: 7
Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Experts by Experience
Gerda de Kuijper, Joke de Haan, Shoumitro Deb, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 23, pp. 15637-15637
Open Access | Times Cited: 7
Sociodemographic and clinical factors associated with prescription of first- versus second-generation long-acting antipsychotics in incarcerated adult males
Enrico Capuzzi, Carla Laura Di Forti, Alice Caldiroli, et al.
International Clinical Psychopharmacology (2023) Vol. 39, Iss. 4, pp. 276-283
Closed Access | Times Cited: 2
Successful Treatment of Tourette Syndrome With a Combination of Guanfacine and Aripiprazole: A Case Series
Tikku George, Mallory Emig, Pratap Chand, et al.
Cureus (2023)
Open Access | Times Cited: 1
Antipsychotic Drug Prescription and Behavioral Problems in Individuals with Intellectual Disability
Gerda Margaretha de Kuijper, Albert Willem Lenderink
Springer eBooks (2022), pp. 4561-4581
Closed Access | Times Cited: 1
Antipsychotic Drug Prescription and Behavioral Problems in Individuals with Intellectual Disability
Gerda Margaretha de Kuijper, Albert Willem Lenderink
Springer eBooks (2021), pp. 1-21
Closed Access | Times Cited: 1
Autism Spectrum Disorder
Donald E. Greydanus, Dilip R. Patel, Dustin C. Rowland
Elsevier eBooks (2021), pp. 396-434
Closed Access | Times Cited: 1
Tic-Störung und Tourette-Syndrom
Peter Weber
Springer eBooks (2023), pp. 179-191
Closed Access
Effectiveness of lifestyle interventions for improving the physical health of children and adolescents taking antipsychotic medications: protocol for a systematic review and meta-analysis
Patrick Hawker, Jessica Bellamy, Catherine McHugh, et al.
BMJ Open (2023) Vol. 13, Iss. 10, pp. e073893-e073893
Open Access
Clozapine's Multiple Cellular Mechanisms: What Do We Know after More than Fifty Years? a Systematic Review and Critical Assessment of Translational Mechanisms Relevant for Innovative Strategies in Treatment-Resistant Schizophrenia
Andrea de Bartolomeis, Licia Vellucci, Annarita Barone, et al.
SSRN Electronic Journal (2022)
Open Access
Page 1

Scroll to top